Fingolimod
Abstract
Reactions 1704, p163 - 2 Jun 2018 Severe aseptic temporal lobe encephalitis: case report A 49-year-old woman developed severe aseptic temporal lobe encephalitis during treatment with fingolimod for relapsing-remitting multiple sclerosis (RRMS). The woman, who had been on fingolimod for 3.5 years [route and dosage not stated] for a 25-year history of RRMS, presented with global aphasia, confusion and holocephalic headache. Additionally, she had been receiving treatment with an angiotensin-II...